NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership Team Will spearhead clinical advancement of the company's innovative NLRP3 inflammasome inhibitor portfolio Brings deep clinical leadership in obesity and cardiometabolic diseases, with a proven track record guiding programs from early-stage development through Phase 3 and regulatory approval Philadelphia, PA, July 21, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 inflammasome, today announces the appointment of Dr. Jyothis George, M.D., Ph.D., …

WOBURN, Mass.--(BUSINESS WIRE)---- $SES #AI--SES AI Corporation (“SES AI”) (NYSE: SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today announced it will release its 2025 second quarter financial results after market close on Monday, August 4, 2025. The Company will hold a conference call on Monday, August 4, 2025, at 5:00 p.m. ET. A webcast of the live conference call will be available through SES's Investor Relations website, https:.

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, and the world's first commercial supplier of quantum computers, announced the results of a new study today that highlights the potential for quantum optimization to create value across industries. According to the study, 46% of surveyed business leaders whose company has implemented quantum optimization or plans to do so within the next.

SAN FRANCISCO--(BUSINESS WIRE)--ON24 (NYSE: ONTF) will release its second quarter 2025 financial results after U.S. markets close on Thursday, August 7, 2025. ON24 management will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its business and financial performance. Event: ON24 Second Quarter 2025 Earnings Call Date: Thursday, August 7, 2025 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Webcast: investors.ON24.com Dial-i.

HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #earnings--BlackSky Technology Inc. (NYSE: BKSY) will host a conference call to discuss second quarter 2025 financial results and its business outlook on Thursday, August 7, 2025, at 8:30 a.m. EDT. A press release with BlackSky's financial results will be released in advance of the conference call that same day. To access the live webcast or the archived webcast following completion of the call, please click here or visit the company's investor relations website at http://ir.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) today announced the execution of an agreement with a leading diversified midstream energy company to develop a new carbon capture and sequestration (“CCS”) project at a currently operating natural gas processing plant in East Texas. The agreement expands on a previously announced agreement between the companies to develop a separate CCS project at a location in South Texas. The new CCS project will be constructed on t.

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that positive results from the Phase 3 OASISplus prospective switch study of donidalorsen in patients with hereditary angioedema (HAE) were published in The Journal of Allergy and Clinical Immunology (JACI) In Practice. Results indicate that patients who switched to donidalorsen from prior prophylactic treatments showed a 62% further reduction in mean monthly HAE attack rate from baseline, and 84% of p.

Randomized sub-trial 1 of a global adaptive platform trial of COM701 maintenance therapy in patients with relapsed platinum sensitive ovarian cancer Trial supported by strong biological rationale and clinical data from patients with advanced ovarian cancer Interim analysis planned for the second half of 2026 HOLON, Israel , July 21, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that the first patient was dosed in the global randomized sub-trial 1 of adaptive platform trial, MAIA-ovarian (which stands for MA intenance Immunotherapy …

NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced compelling immunologic findings from the treatment of a moderate Alzheimer's Disease (AD) patient with intranasal foralumab.

Singapore, July 21, 2025 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a leading innovator in travel technology and retail solutions, is proud to announce the launch of its groundbreaking AI Travel Assistant—a wearable device poised to redefine the travel experience for millions of global travelers.

PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m.

LONDON , July 21, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), a division of S&P Global (NYSE: SPGI) and the world's leading index provider, today announced that it has entered into a definitive agreement to acquire ARC Research, a subsidiary of ARC Group, and the leading independent provider of investment performance data, benchmarking capabilities and insights in the private wealth market. ARC Research maintains the world's largest proprietary dataset of more than 500,000 private client portfolios spanning over two decades.

RACINE, Wis. , July 21, 2025 /PRNewswire/ -- Modine (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that Alan Lowe joined the Company's Board of Directors effective July 18, 2025.

The agreement with BNW Real Estate Development LLC positions NewGenDigital to maximize the profitability of its recently acquired plot of land in the UAE

BARCELONA, Spain , July 21, 2025 /PRNewswire/ -- Freightos (NASDAQ: CRGO), the leading digital booking and payment platform for the international freight industry, today announced that SriLankan Cargo, the air freight arm of SriLankan Airlines, has partnered with WebCargo for online air cargo booking and payments. This partnership, which is planned to go live later this quarter, significantly strengthens Freightos' footprint in South Asia and unlocks digital access to Colombo—a growing transshipment hub linking the Indian subcontinent with the Middle East, Southeast Asia, and Europe.

ADDISON, Texas--(BUSINESS WIRE)-- #gnty--Guaranty Bancshares, Inc. (NYSE: GNTY) (the "Company," "we," "us," or "our"), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), today reported financial results for the fiscal quarter ended June 30, 2025. The Company's net income available to common shareholders was $10.0 million, or $0.88 per basic share, for the quarter ended June 30, 2025, compared to $8.6 million, or $0.76 per basic share, for the quarter ended March 31, 2025 and $7.4 milli.

The wireless carrier hiked its outlook for earnings per share and free cash flow on Monday.

EVERETT, Wash.--(BUSINESS WIRE)--Funko, Inc. (Nasdaq: FNKO), a leading pop culture lifestyle brand, today announced that it will host a conference call on Thursday, August 7, 2025, at 4:30 p.m. ET to discuss its financial results for the second quarter ended June 30, 2025. The conference call will be webcast and can be accessed on the investor relations section of the Funko website at https://investor.funko.com. After the call, a replay of the webcast will be available on the same website. Abou.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025.

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #FDA--BMS's Supplemental New Drug Application for Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis Accepted for Review.